华海药业
(600521)
| 流通市值：271.06亿 | | | 总市值：271.06亿 |
| 流通股本：14.67亿 | | | 总股本：14.67亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,446,524,268.72 | 1,591,042,171.54 | 2,836,294,473.25 | 1,342,428,316.73 |
| 应收票据及应收账款 | 2,665,677,209.52 | 2,847,738,349.71 | 2,428,524,612.36 | 2,481,198,061.9 |
| 应收账款 | 2,665,677,209.52 | 2,847,738,349.71 | 2,428,524,612.36 | 2,481,198,061.9 |
| 应收款项融资 | 82,677,692.97 | 106,386,267.3 | 110,252,716.93 | 75,643,999.86 |
| 预付款项 | 122,890,125.92 | 101,327,402.73 | 76,825,776.72 | 61,645,517.86 |
| 其他应收款合计 | 40,584,000.37 | 22,853,008.06 | 24,378,703.56 | 28,397,921.55 |
| 存货 | 3,479,075,472.55 | 3,236,932,126.42 | 3,236,962,151.59 | 3,432,132,350.93 |
| 其他流动资产 | 71,991,565.52 | 149,490,028.22 | 128,147,175.2 | 107,210,953.19 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 7,980,130,228.56 | 8,120,384,717.03 | 8,901,797,081.57 | 7,621,698,796.25 |
| 非流动资产: | | | | |
| 长期股权投资 | 419,875,240.09 | 428,470,854.44 | 410,319,572.86 | 417,871,184.53 |
| 其他权益工具投资 | 55,361.17 | 55,361.17 | 55,361.17 | 55,361.17 |
| 其他非流动金融资产 | 367,351,780.71 | 332,506,308.19 | 335,124,579.88 | 367,318,727.28 |
| 投资性房地产 | 5,776,793.3 | 5,909,348.91 | 6,038,604.52 | 6,167,860.14 |
| 固定资产 | 6,004,219,141.62 | 5,651,088,410.65 | 5,723,107,557.69 | 5,619,570,412.87 |
| 在建工程 | 2,371,790,304 | 2,583,720,417.51 | 2,341,182,414.3 | 2,316,895,370.32 |
| 使用权资产 | 44,810,149.4 | 49,104,031.27 | 53,540,482.9 | 57,577,685.86 |
| 无形资产 | 1,214,382,635.76 | 1,209,688,062.96 | 1,104,471,059.65 | 1,113,059,428.02 |
| 开发支出 | 862,737,456.92 | 842,000,694.32 | 811,795,661.1 | 796,284,582.75 |
| 商誉 | 64,445,908.06 | 64,445,908.06 | 64,445,908.06 | 64,445,908.06 |
| 长期待摊费用 | 39,283,887.13 | 40,610,950.88 | 43,535,579.54 | 46,756,465.53 |
| 递延所得税资产 | 180,330,890.61 | 185,459,884.89 | 188,903,316.62 | 171,989,082.31 |
| 其他非流动资产 | - | - | 105,000,000 | 278,747.75 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 11,575,059,548.77 | 11,393,060,233.25 | 11,187,520,098.29 | 10,978,270,816.59 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 19,555,189,777.33 | 19,513,444,950.28 | 20,089,317,179.86 | 18,599,969,612.84 |
| 流动负债: | | | | |
| 短期借款 | 1,484,714,448.9 | 1,884,683,357.81 | 2,424,668,913.34 | 1,582,547,399.16 |
| 应付票据及应付账款 | 1,562,779,661.44 | 1,525,868,158.38 | 1,386,892,242.34 | 1,386,756,384.16 |
| 其中：应付票据 | 508,509,424.16 | 452,720,174.66 | 437,434,531.45 | 442,950,342.85 |
| 应付账款 | 1,054,270,237.28 | 1,073,147,983.72 | 949,457,710.89 | 943,806,041.31 |
| 合同负债 | 40,063,972.94 | 34,733,556.6 | 36,792,226.41 | 33,509,357.44 |
| 应付职工薪酬 | 164,425,997.67 | 157,624,036.59 | 165,667,062.04 | 270,518,727.94 |
| 应交税费 | 117,812,207.8 | 120,129,217.14 | 133,952,711.02 | 163,172,665.54 |
| 其他应付款合计 | 926,780,292.91 | 953,950,414.62 | 808,453,943.02 | 646,780,812.69 |
| 一年内到期的非流动负债 | 1,384,717,816.9 | 1,034,253,209.34 | 1,744,570,678.47 | 1,359,673,109.72 |
| 其他流动负债 | 2,474,787.51 | 2,203,645.68 | 2,389,635.28 | 2,296,874.29 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 5,683,769,186.07 | 5,713,445,596.16 | 6,703,387,411.92 | 5,445,255,330.94 |
| 非流动负债: | | | | |
| 长期借款 | 2,151,225,000 | 2,079,850,000 | 2,161,650,000 | 2,205,190,000 |
| 应付债券 | 1,886,054,610.51 | 1,862,873,196.95 | 1,839,944,755.2 | 1,817,016,286.05 |
| 租赁负债 | 34,306,112.51 | 37,969,178.84 | 41,219,557.03 | 44,927,019.07 |
| 预计负债 | 156,247,825.2 | 160,995,317.74 | 162,508,541 | 167,246,906.46 |
| 递延收益 | 684,860,824.36 | 690,230,164.31 | 686,754,732.71 | 665,441,380.05 |
| 其他非流动负债 | 3,777,750 | 3,777,750 | 3,777,750 | 3,777,750 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 4,916,472,122.58 | 4,835,695,607.84 | 4,895,855,335.94 | 4,903,599,341.63 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 10,600,241,308.65 | 10,549,141,204 | 11,599,242,747.86 | 10,348,854,672.57 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,466,755,454 | 1,466,755,454 | 1,482,507,145 | 1,482,507,116 |
| 其他权益工具 | 240,135,087.81 | 240,135,087.81 | 240,135,218.15 | 240,135,348.49 |
| 资本公积 | 1,174,057,932.36 | 1,169,994,899.11 | 1,306,949,312.27 | 1,296,393,171.86 |
| 减:库存股 | 300,046,387.8 | 300,046,387.8 | 455,321,591.72 | 416,909,016.79 |
| 其他综合收益 | -4,943,616.19 | 1,717,863.83 | 705,317.85 | 1,185,121.63 |
| 专项储备 | 3,103,568.63 | 3,327,010.85 | 3,182,971.73 | 3,104,862.19 |
| 盈余公积 | 745,795,769.54 | 745,795,769.54 | 745,795,769.54 | 745,795,769.54 |
| 未分配利润 | 5,467,667,815.52 | 5,474,780,731.08 | 4,995,482,317.49 | 4,724,639,528.27 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 8,792,525,623.87 | 8,802,460,428.42 | 8,319,436,460.31 | 8,076,851,901.19 |
| 少数股东权益 | 162,422,844.81 | 161,843,317.86 | 170,637,971.69 | 174,263,039.08 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 8,954,948,468.68 | 8,964,303,746.28 | 8,490,074,432 | 8,251,114,940.27 |
| 负债和股东权益合计 | 19,555,189,777.33 | 19,513,444,950.28 | 20,089,317,179.86 | 18,599,969,612.84 |
| 公告日期 | 2024-10-31 | 2024-08-31 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |